Article by Barbara Toman
A young person’s sudden death from cardiac arrest is doubly devastating. Just when family members are mourning the unexpected loss, they might also be wondering if tArhe cause was inherited heart disease — and if they too are at risk.
there’s no easy answer. Unlike certain cancers with strong links to a single
gene abnormality, cardiovascular disease is associated with complex genetic
factors. Blood relatives of people who experienced sudden cardiac death can
face a lifetime of uncertainty and annual medical imaging to detect any signs
of heart disease.
With support from the Center for Individualized Medicine, Mayo Clinic is conducting research to find answers.
“Surviving family members don’t know if they are at risk for a heart condition, if they should change their lifestyle such as not engaging in certain types of athletics— they’re just stuck,” says Joseph Maleszewski, M.D., a Mayo Clinic pathologist specializing in cardiovascular disease. “We’re trying to elucidate the underlying genetic implications for these family members. We want to help them manage diagnostic screening and get the care they need right now.”
unexpected death from cardiac arrest accounts for 12% to 15% of natural deaths.
Up to half of people under age 35 who experience sudden cardiac death had no
family history of it and no warning signs of heart disease, according to the
National Society of Genetic Counselors.
in partnership with the Windland Smith Rice Sudden Death Genomics Laboratory
& Long QT Syndrome Clinic, Mayo Clinic’s research involves postmortem
analysis of the hearts from people under age 40 who died suddenly of presumed
cardiac causes, and genetic testing of first-degree relatives—parents, siblings
and children. “We believe it’s absolutely necessary to combine these two
approaches in order to give the family information that’s much more useful than
what they would get from either approach alone,” Dr. Maleszewski says.
Subtle signs that lead to answers
common challenge for family members is incomplete information about the cause
of a relative’s sudden death. An autopsy might establish that the person died
of natural causes but fail to identify a specific cardiac disease or its
believe some cases of sudden cardiac death are very subtle manifestations of
cardiomyopathy, or heart muscle disease. The features of cardiomyopathies are
sometimes very difficult to detect, even by experienced medical examiners and
coroners,” Dr. Maleszewski says.
postmortem examinations conducted by Mayo Clinic cardiovascular pathologists will
evaluate each heart’s overall appearance and analyze tissue sections under the
microscope. If cardiomyopathy is suspected, genetic testing will be recommended
for first-degree relatives.
who test negative for genetic variants associated with heart disease can avoid
routine imaging. For family members who do have a genetic variant, risk-management
plans can be developed.
think this is a much more scientific and comprehensive approach to cases of
sudden death,” Dr. Maleszewski says. “Instead of a 20th-century
screening paradigm, we want a 21st-century pairing of postmortem examination and
is key. “There’s a lot of nuance in the understanding of cardiovascular disease.
Our interpretation of the genetic tests is completely contingent on
establishing with our eyes that there is some type of underlying pathology in
the heart,” Dr. Maleszewski says. “We can then give information to
the family that empowers them to obtain efficient screening and to have
common challenge is a lack of genetic information about the deceased relative.
Postmortem blood samples are stored for a limited time — due to cost and space
constraints experienced by medical examiners — and so often aren’t available
for genetic testing.
Clinic has developed a unique genetic test that uses tissue samples preserved
in paraffin. Unlike blood samples, those tissue samples are often kept by
medical examiners for several years to meet accreditation requirements.
use this tissue-based genetic testing routinely. It opens up a lot of older
cases for possible interrogation,” Dr. Maleszewski says. “For
example, if a Mayo cardiologist sees a patient whose father had cardiac death
at a young age, we can obtain the father’s tissue samples, examine them and
then determine if genetic testing should be done to assess the son’s risk.”
accumulated will also provide insight into the complex genetic variations that
can cause heart disease.
we hope that for every case of sudden cardiac death, there can be a complete
workup of the heart and the genetics,” Dr. Maleszewski says. “We’d
like to help educate medical examiners and coroners on how to perform a thorough
cardiovascular exam to look for these subtle signs of disease, and to give them
access to expert consultation when they need it.”
Clinic’s study is being conducted through medical examiners and coroners who
refer new cases of sudden death in which a cardiac cause is strongly suspected.
to read more stories like this one?
Register to get weekly updates about new
stories on Mayo Clinic Center for Individualized Medicine blog.
from and network with researchers and innovators in oncology at
Medicine 2019 Conference: Precision Cancer Care through Immunotherapy and